Navigation Links
Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn
Date:10/8/2007

SANTA MONICA, Calif., Oct. 8 /PRNewswire-USNewswire/ -- Proposed regulations that would govern who owns and controls discoveries resulting from California stem cell research grants to for-profit organizations fail to ensure affordable access to the drugs and cures for California taxpayers paying for the research, the Foundation for Taxpayer and Consumer Rights (FTCR) said today.

"To ensure that the people who have paid for the research to develop these drugs have this affordable access, there must be a provision allowing for intervention by the state attorney general if the drugs are priced unreasonably," wrote John M. Simpson, FTCR Stem Cell Project director, in comments filed with the California Institute for Regenerative Medicine (CIRM).

Read FTCR's comments here: http://www.consumerwatchdog.org/resources/FTCRIPcomment100507.pdf .

The regulations are being reviewed through the state's Office of Administrative Law and will have the full force of law when completed. The most recent proposal was open for public comment and those comments must be considered before the regulations can be implemented.

FTCR also said that a provision in the proposed Intellectual Property (IP) Regulations for For-Profit Organizations that would have tied some stem cell cure prices to the California Prescription Discount Drug Program, (Cal-Rx) was rendered meaningless by Gov. Arnold Schwarzenegger's action on the state budget. In the deal that allowed the state budget to be approved, Schwarzenegger line-item vetoed the money that would have implemented Cal-Rx.

"Clearly, any provisions in the IP policies that intend to implement favorable pricing must rely entirely on the IP regulations under CIRM's auspices and not on some outside scheme that is highly subject to political whim," wrote Simpson.

Simpson wrote that the revised regulations were clearer and less ambiguous than an early version. He added, "Sadly, however, if the proposed regulations lack an essential provision - in this case a provision that guarantees affordable access for all Californians - it matters little how clear they are."

Proposition 71, passed in 2004, creates a $6 billion stem cell research program and the California Institute for Regenerative Medicine to oversee it. So far CIRM's oversight committee has approved about $210 million in research, training and facilities grants. Last week the state sold the first $250 million in bonds to finance the research program.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at: http://www.ConsumerWatchdog.org and http://www.oilwatchdog.org.


'/>"/>
SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Revised Pregnancy Counselling Item Still Flawed
2. Royal College Issues Revised Guidelines for Face Transplantation
3. Government Allot More Funds for Revised TB Program
4. Revised Cholesterol Guidelines Causes Concern Among Medical Community
5. Uttar Pradesh to Declare Revised Medical Entrance Results
6. Passive smoking declared as Toxic in California
7. California Employers may need to Fork out more on Health Benefits
8. An urgent need for prison reforms: California!
9. Death by Smog in California
10. PE Minimums Violations:California Schools Blamed
11. California: Go Ahead For Drug Discount Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, ... ... and security executive networking and relationship-marketing firm, announced today that nominations will ... Information Security Executive® (ISE®) West Awards. , Awards include the Information ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... The ... annually in this country. The AutismOne 2016 Conference, which is being held May 25-29 ... often won’t hear elsewhere about helpful interventions and causes of chronic illness in children. ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood ... his medical and surgical expertise. Technically known as deoxycholic acid or previously as ... a non-surgical alternative for reduction of fat below the chin (aka the “double ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... disorder treatment helps to reduce the frequency and level of relapse. ... Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of the recovery ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> Research and ...
(Date:2/5/2016)... , Feb. 5, 2016  Venice,s newest ... is the first of its kind in the ... tattoos through advanced laser treatment. The physician-owned and ... Suncoast by storm with its revitalizing ... and advanced multi-wavelength Astanza Trinity technology. ...
(Date:2/5/2016)... Feb. 5, 2016 Dehaier Medical Systems ... the "Company"), which develops, markets and sells medical ... China and international markets, today ... aims to concentrate the Company,s resources to develop ... business and to focus more on its major ...
Breaking Medicine Technology: